Fear of pain moderates the relationship between self-reported fatigue and methionine allele of catechol-O-methyltransferase gene in patients with fibromyalgia
Open Access
- 28 April 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (4) , e0250547
Abstract
Previous research has shown a consistent association among genetic factors, psychological symptoms and pain associated with fibromyalgia. However, how these symptoms interact to moderate genetic factors in fibromyalgia has rarely been studied to date. The present research investigates whether psychological symptoms can moderate the effects of catechol-O-methyltransferase on pain and fatigue. A total of 108 women diagnosed with fibromyalgia and 77 healthy control participants took part in the study. Pain, fatigue, and psychological symptoms (anxiety, depression, pain catastrophizing, fear of pain and fear of movement) were measured by self-report questionnaires. Two types of statistical analyses were performed; the first was undertaken to explore the influences of COMT genotypes on clinical symptoms by comparing patients with fibromyalgia and healthy controls. In the second analysis, moderation analyses to explore the role of psychological symptoms as potential factors that moderate the relationship between pain/fatigue and COMT genotypes were performed. The main results indicated that patients carrying the Met/Met genotype reported significantly higher levels of fatigue than heterozygote carriers (i.e., Met/Val genotype) and higher levels of fatigue, but not significantly different, than Val homozygote carriers. Among patients with fibromyalgia carrying methionine alleles (i.e., Met/Met + Met/Val carriers), only those who scored high on medical fear of pain, experienced an intensified feeling of fatigue. Thus, the present research suggests that fear of pain, as a psychological symptom frequently described in fibromyalgia may act as a moderating factor in the relationship between the Met allele of the COMT gene and the increase or decrease in self-reported fatigue. Although further research with wider patient samples is needed to confirm the present findings, these results point out that the use of psychological interventions focused on affective symptomatology might be a useful tool to reduce the severity of fibromyalgia.Keywords
Funding Information
- Comunidad de Madrid (S2015/HUM-3327 EMO-CM)
- Comunidad de Madrid (PEJD-2017-PRE/SOC-3501)
- Ministerio de Economía y Competitividad (PSI2017-85241-R)
- Comunidad de Madrid (SAPIENTIA-CMH2019/HUM-5705)
This publication has 69 references indexed in Scilit:
- Beyond pain in fibromyalgia: insights into the symptom of fatigueArthritis Research & Therapy, 2013
- COMT moderates the relation of daily maladaptive coping and pain in fibromyalgiaPain, 2011
- Fatigue in fibromyalgia: a conceptual model informed by patient interviewsBMC Musculoskeletal Disorders, 2010
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- Patient perspectives on the impact of fibromyalgiaPatient Education and Counseling, 2008
- Evidence for a biopsychosocial influence on shoulder pain: Pain catastrophizing and catechol- O -methyltransferase (COMT) diplotype predict clinical pain ratingsPain, 2008
- Cancer-related fatigue: Links with inflammation in cancer patients and survivorsBrain, Behavior, and Immunity, 2007
- Catechol- O -methyltransferase inhibition increases pain sensitivity through activation of both β2- and β3-adrenergic receptorsPain, 2007
- Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgiaArthritis Research & Therapy, 2007
- Health status and disease severity in fibromyalgia. Results of a six‐center longitudinal studyArthritis & Rheumatism, 1997